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Abstract: Background: Membrane-active antimicrobial peptides (AMPs) are interesting candidates 
for the development of novel antimicrobials. Although their effects were extensively investigated in 
model membrane systems, interactions of AMPs with living microbial membranes are less known 
due to their complexity. The aim of the present study was to develop a rapid fluorescence-based 
microplate assay to analyze the membrane effects of AMPs in whole Staphylococcus aureus and 
Staphylococcus epidermidis. Methods: Bacteria were exposed to bactericidal and sub-inhibitory 
concentrations of two membrane-active AMPs in the presence of the potential-sensitive dye 3,3’-
dipropylthiadicarbocyanine iodide (diSC3(5)) and the DNA staining dye propidium iodide (PI), to 
simultaneously monitor and possibly distinguish membrane depolarization and membrane 
permeabilization. Results: The ion channel-forming gramicidin D induced a rapid increase of 
diSC3(5), but not PI fluorescence, with slower kinetics at descending peptide concentrations, 
confirming killing due to membrane depolarization. The pore-forming melittin, at sub-MIC and 
bactericidal concentrations, caused, respectively, an increase of PI fluorescence in one or both dyes 
simultaneously, suggesting membrane permeabilization as a key event. Conclusions: This assay 
allowed the distinction between specific membrane effects, and it could be applied in the mode of 
action studies as well as in the screening of novel membrane-active AMPs. 
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The World Health Organization (WHO) identified antibiotic-resistant bacteria as one of the 
greatest threats to human health in the future [1]. There is an urgent need for novel antimicrobial 
agents acting on thus far unexploited targets. Several antimicrobial peptides (AMPs) have been 
proposed as potential candidates for the development of novel antimicrobials [2–4]. Among them, 
those exerting their bactericidal action by membrane permeabilization are particularly interesting 
[2,4]. The cytoplasmic membrane of bacteria may be regarded as a valid target for at least two reasons: 
(i) it is essential because it is the site where processes crucial for bacterial survival take place, and (ii) 
it is a conserved non-protein structure which cannot be easily modified without the risk of losing its 
functional and structural integrity, making the emergence of resistance less likely [5]. In addition, the 
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cytoplasmic membrane could be targeted also in dormant, quiescent cells such as those forming 
biofilms [6]. In fact, the membrane-targeting AMPs are bactericidal and have generally broad-
spectrum activity also including biofilms [7,8]. 
In the past decades, membrane interactions of AMPs have been extensively investigated by 
using model membrane systems, and on this basis, several models of peptide-membrane interaction 
have been proposed [4,9–11]. However, due to the complexity of living microbial membranes [12–
14], interactions of AMPs with whole bacteria may occur in a different way and possibly lead to 
different consequences [15–17]. In almost all species the cytoplasmic membrane is surrounded by a 
peptidoglycan layer, which is particularly thick in Gram-positive bacteria [13], but it is usually freely 
permeable to AMPs. On the contrary, the outer membrane in the external envelope of Gram-negative 
microorganisms with its peculiar lipid composition [18] represents an important permeability barrier 
[19], which can, however, be overcome by many AMPs [3]. Of course, all the processes related to 
peptidoglycan and/or lipopolysaccharide metabolisms require structural contiguity and functional 
interconnections with the cytoplasm through the plasma membrane [20–22]. Hence, events occurring 
at the bacterial cytoplasmic membrane, or at other levels of the external envelope, may have 
important repercussions on the cell interior [20,23], and vice versa the inhibition of vital intracellular 
processes can drastically modify membrane integrity [17]. Membrane-targeting AMPs can affect 
membrane functions by increasing the membrane permeability to small ions or to larger molecules, 
or by causing large-scale membrane damage [15,16,24,25]. To analyze the mode of action of 
membrane-targeting AMPs, membrane-impermeable fluorescent dyes such as propidium iodide (PI) 
[26] or SYTOX green [27] are frequently employed. Their fluorescence increases upon their binding 
to nucleic acids, which happens when membrane integrity is critically damaged or large pores are 
formed [27]. For this reason, they are also used to discriminate between viable and dead bacteria [26]. 
These dyes, however, are not suitable to detect modifications in membrane permeability to small 
ions, which may be lethal to bacteria also in the absence of evident membrane lesions [28,29]. The 
modifications in ion permeability could be studied using membrane potential-sensitive fluorescent 
probes such as the oxonol bis-(1,3-dibutylbarbituric acid)trimethine oxonol (DiBAC4(3)) [30], or 
carbocyanine dyes such as 3,3’-dihexyloxacarbocyanine iodide (DiOC6(3)) [31] and 3,3’-
dipropylthiadicarbocyanine iodide (diSC3(5)) [32]. These are lipophilic dyes, with the difference that, 
at physiological pH oxonols are anionic, while carbocyanines carry a positive charge [33]. This 
implies that DiBAC4(3) cannot penetrate the polarized membrane of living microorganisms, and only 
enters depolarized cells, displaying enhanced fluorescence and red spectral shift upon binding to 
intracellular proteins [26,34]. On the other hand, carbocyanines such as diSC3(5) accumulate on 
polarized membranes resulting in self-quenching of fluorescence [35,36]. Upon membrane 
depolarization, the dye is released and fluorescence de-quenched. In many studies, these dyes were 
used alone or in combination with PI, as a means to evaluate bacterial viability [37,38], antibiotic 
susceptibility [39,40], and to monitor the physiological state of individual microbial cells [41] by flow 
cytometry. Furthermore, these dyes were applied in mode-of-action studies to specifically analyze 
membrane depolarization of Gram-positive [28,42,43] and Gram-negative [32,44,45] microorganisms 
upon treatment by different AMPs, or other membrane-active compounds [29,46]. In these studies, 
the fluorescence was measured by flow cytometry [42], spectrofluorimetry by using cuvettes 
[28,32,43–45] or microplates [29,46]. An advantage of using a microplate reader, equipped with the 
temperature control system, is the possibility to follow the changes in fluorescence kinetically and, in 
addition, to monitor several samples simultaneously. Both, the oxonol DiBAC4(3) and the 
carbocyanine dye diSC3(5) have been proposed for kinetic monitoring of changes in membrane 
polarity of Gram-positive bacteria exposed to antimicrobial compounds [34,47]. 
In the present study, we partially adapted these latter methods to two Gram-positive species 
representing important human pathogens, namely Staphylococcus aureus and Staphylococcus 
epidermidis. S. aureus has been ranked by WHO as a high priority pathogen for the development of 
new antibiotics, mainly due to the high prevalence of methicillin-resistance and increasing resistance 
to vancomycin [48]. S. epidermidis represents an emerging opportunistic pathogen responsible for 
foreign-body associated infections due to its ability to form biofilm [49]. Hence, both species may be 
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considered as suitable targets for the set-up of a novel screening method of membrane-active 
compounds effective against Gram-positive microorganisms. Moreover, from a practical point of 
view, as their envelope is devoid of the outer membrane, the Gram-positives have the technical 
advantage that there is no need for any preliminary permeabilization step, avoiding the risk of 
artefactual results [31]. The aim of the present study was to develop a rapid fluorescence-based 
microplate assay to get mechanistic and kinetic insights into the interaction of membrane-active 
AMPs, such as the ion channel-forming gramicidin D [50], and the pore-forming melittin [51], with 
cytoplasmic membranes of whole S. epidermidis and S. aureus. By combining the potentiometric dye 
diSC3(5) with the DNA-staining dye PI, it was possible to simultaneously monitor the peptide-
induced phenomena of membrane depolarization due to ion movements across the membrane, and 
membrane permeabilization due to the formation of pores, and thus to distinguish between specific 
membrane effects due to different modes of peptide-membrane interaction. 
2. Results 
2.1. Compatibility between the Fluorescent Dyes 
The spectroscopic properties of two potentiometric dyes, the oxonol DiBAC4(3) and the 
carbocyanine diSC3(5), and of the DNA stain PI, were evaluated in our assay conditions by measuring 
fluorescence with a microplate reader by using the reported wavelength values for excitation and 
emission maxima [30,35,52–54]. These values were confirmed when spectra were measured separately 
(see Supplementary Figure S1 and S2). However, as evident from Figure 1, when DiBAC4(3) was 
combined with PI, we observed strong interference of PI towards DiBAC4(3) (Figure 1A,B). This finding 
precluded the use of the combination DiBAC4(3) + PI in our fluorescence assay. On the other hand, the 
fluorescence of diSC3(5) was not affected by PI (Figure 1C,D) and vice versa (Figure 1E,F), thus allowing 
their combined use for our purposes. 
 
Figure 1. Fluorescence excitation (A) and emission (B) spectra of bis-(1,3-dibutylbarbituric 
acid)trimethine oxonol (DiBAC4(3)) + Propidium Iodide (PI) and fluorescence excitation (C,E) and 
emission (D,F) spectra of 3,3’-dipropylthiadicarbocyanine iodide (diSC3(5)) +/− PI. (A) Excitation 
spectra with 516 nm detection wavelength (DiBAC4(3) emission maximum); (B) emission spectra with 
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496 nm excitation wavelength (DiBAC4(3) excitation maximum) of three different DiBAC4(3) 
concentrations + 10 µg/mL PI; (C,E) excitation spectra with 672 nm (diSC3(5) emission maximum) and 
617 nm (PI emission maximum) detection wavelengths, respectively, and (D,F) emission spectra with 
652 nm (diSC3(5) excitation maximum) and 490 nm (PI excitation maximum) excitation wavelengths, 
respectively, of 400 nM diSC3(5) + 20, 10, and 5 µg/mL PI. For technical reasons due to instrument 
settings, spectra in (A–D) could not be measured at wavelengths >496 nm, <510 nm, >650 nm, and 
<670 nm, respectively. In (A), (C), and (D) error bars were omitted for clarity. 
2.2. Selection of Membrane-Active Peptides 
The next step was to find the antimicrobial peptide (AMPs) candidates as positive controls for 
membrane depolarization and/or membrane permeabilization events. Based on scientific literature, 
four membrane-active AMPs were selected: gramicidin D, cecropin A, magainin 2, and melittin. The 
insect peptide cecropin A [55], the frog peptide magainin 2 [56], and the cytolytic peptide melittin 
from bee venom [51], are all cationic α-helical AMPs known to permeabilize bacterial membranes 
[57]. Melittin, in particular, is well-known as a pore-forming peptide [11]. Gramicidin D is a bacterial 
antibiotic produced by Bacillus brevis [58,59]. It is composed of a mixture of highly similar 
pentadecapeptides consisting of about 85% gramicidin A [50]. The principal structural features of this 
peptide are alternating hydrophobic L- and D-amino acid residues and their organization in the 
membrane environment leads to the formation of an ion channel [50]. The antimicrobial activity of 
these peptides was evaluated against representative Gram-positive and Gram-negative bacterial 
species in a standard minimum inhibitory concentration (MIC) assay. Results in Table 1 show that 
only melittin and gramicidin D displayed activities against S. aureus and S. epidermidis, which are the 
principal target of the present study. These two peptides were thus selected for further experiments. 
Table 1. Antimicrobial activities of selected antimicrobial peptides (AMPs) against reference strains. 
 Cecropin A Melittin Magainin 2 Gramicidin D 
MIC (MBC) (µM) a,b 
S. epidermidis ATCC 35984 >128 0.5 (0.5) >128 2 (4) 
S. aureus ATCC 25923 >128 0.5 (1) 64 (128) 4 (8) 
E. coli ATCC 25922 0.75 (0.75) 1 (1) 8 (16) >32 
P. aeruginosa ATCC 27853 1 (2) 1 (2) 64 (64) >32 
a Determined in MH broth at 5 × 105 CFU/mL. b Data are means of at least 2 independent experiments. 
2.3. Interference of Peptides and Uncouplers with the Fluorescent Dyes 
To verify whether the selected peptides could affect the fluorescence of diSC3(5) or PI, the 
fluorescence of both probes combined together was monitored kinetically in the presence of each 
AMP. Two widely used uncouplers, i.e., carbonyl cyanide 3-chlorophenylhydrazone (CCCP) and 
carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP), to be possibly used as controls of 
complete depolarization, were also included in these experiments. As shown in Figure 2, both 
uncouplers decreased diSC3(5) fluorescence, in line with the report of te Winkel et al. [34], whereas 
the peptides did not. No interference between PI and the added molecules was recorded. 
Unfortunately, the interference of the uncouplers with diSC3(5) fluorescence precluded their use in 
this assay. 
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Figure 2. Interference of uncouplers and peptides with the fluorescent dyes. The kinetics of (A) 
diSC3(5) (λex = 652 nm, λem = 672 nm) and (B) PI (λex = 535 nm, λem = 617 nm) are shown in separate 
graphs for clarity purposes. The time necessary for the addition of peptides and uncouplers (indicated 
by *) was about 6 min. 
2.4. Monitoring of Peptide-Induced Membrane Alterations with the Combination of diSC3(5) and PI 
To monitor the phenomena of membrane depolarization and membrane permeabilization 
simultaneously, S. epidermidis ATCC 35984 or S. aureus ATCC 25923 were incubated with the ion 
channel-forming gramicidin D, or with the pore-forming melittin, in PBS-glc containing 400 nM 
diSC3(5) and 5 µg/mL PI at 37 °C in 96-well black microtiter plates (Optiplate, PerkinElmer, Waltham, 
MA, USA). Fluorescence was measured throughout the assay and, at 30 min incubation, aliquots were 
taken to determine bacterial viability by colony forming units (CFU) counts. 
Figure 3 shows that in both Staphylococcus spp. gramicidin D induced a significant increase of 
diSC3(5) (Figure 3A,D), but not of PI fluorescence (Figure 3B,E). The increase was rapid at bactericidal 
concentrations (0.5–15 µM, >92% killing (Figure 3C,F)), while it slowed down, with more sigmoidal 
shapes, at descending peptide concentrations (62.5–125 nM) that also produced lower killing (80%). 
Remarkably, all curves reached more or less the same maximum fluorescence values, although with 
different slopes and thus, at different times. There was a clear correlation between gramicidin D 
concentrations, bacterial killing, and diSC3(5) fluorescence kinetics (Figure 3A,C,D,F), whereas in 
none of the cases PI fluorescence increased (Figure 3B,E). In addition, it is important to note that 
diSC3(5) and PI per se were not toxic to bacteria because in the absence of gramicidin D neither of the 
two probes showed an increase of fluorescence (Figure 3A,B,D,E), or caused a decrease of CFUs (data 
not shown). 
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Figure 3. Membrane depolarization (diSC3(5)) (A,D), permeabilization (PI) (B,E) and killing (C,F) of 
S. epidermidis (A–C) and S. aureus (D–F) caused by gramicidin D. Experiments were performed with 
108 CFU/mL of the indicated strains in PBS-glc with 400 nM diSC3(5) (λex = 652 nm, λem = 672 nm) and 
5 µg/mL PI (λex = 535 nm, λem = 617 nm) at 37 °C. CFU counts were determined at 30 min incubation. 
For clarity purposes diSC3(5) and PI kinetics are in separate graphs, error bars were omitted and only 
the initial 20’ are shown. (*) peptide addition. 
The results obtained with melittin gave a completely different picture (Figure 4). This pore-
forming peptide caused a remarkable, dose-dependent increase of PI fluorescence (Figure 4B,E), with 
a slower increase at sub-MIC (62.5–125 nM) and more rapid kinetics at bactericidal concentrations 
(0.25–1 µM, killing >95%) (Figure 4C,F). DiSC3(5) fluorescence increased only at bactericidal melittin 
concentrations (0.25–1 µM) (Figure 4A,D). 
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Figure 4. Membrane depolarization (diSC3(5)) (A,D), permeabilization (PI) (B,E) and killing (C,F) of 
S. epidermidis (A–C) and S. aureus (D–F) caused by melittin and gramicidin D. Experiments were 
performed with 108 CFU/mL of the indicated strains in PBS-glc containing 400 nM diSC3(5) (λex = 652 
nm, λem = 672 nm) and 5 µg/mL PI (λex = 535 nm, λem = 617 nm) at 37 °C. CFU counts were determined 
at 30 min incubation. The kinetics of diSC3(5) and PI are shown in separate graphs and error bars were 
omitted for clarity. (*) peptide addition. 
2.5. Morphology of Peptide-Treated S. epidermidis 
To investigate whether the distinct membrane effects induced by melittin and gramicidin 
resulted in different morphology of treated bacteria, at the end of fluorescence kinetics (i.e., 30-min 
time point, around 20 min incubation with peptides) bacteria were processed for analysis by Field 
Emission Scanning Electron Microscopy (FE-SEM). The micrographs revealed clear differences in 
bacterial morphology and an evident decrease in bacterial density in treated samples compared to 
untreated controls, in line with the CFU determinations performed in parallel. Images of untreated 
bacteria (Figure 5A,B) show the normal, round and smooth appearance of vital and growing 
staphylococcal cells. 
On the contrary, images of peptide-treated samples show, besides cells with normal appearance, 
bacteria with remarkably altered morphology. Upon treatment with gramicidin, several cells 
presented indents, similar to what observed by Hartmann et al. with gramicidin S [60], or looked 
deflated (Figure 5D). Furthermore, on the surface of many gramicidin-treated cells, there were 
protrusions similar to blebs. However, in some cases, these protrusions could be explained 
alternatively as remains of cytoplasmic material derived from lysed cells (Figure 5C). Deflated, 
“ghost-like” cells were observed also upon treatment with melittin (Figure 5G,H), in line with the 
atomic force microscopy analysis by Roncevic et al. [61]. In some cases, bacteria seemed to collapse 
(Figure 5E), whereas in others they appeared shriveled as raisins (Figure 5F), without macroscopic 
surface lesions like blebs or blisters. 
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Figure 5. Morphology of S. epidermidis, untreated (A,B) or treated with 30 µM gramicidin D (C,D), 1 
µM melittin (E,F) and 125 nM melittin (G,H) analyzed by Field Emission Scanning Electron 
Microscopy (FE-SEM). Arrows indicate, respectively, division septa ( ), blebs ( ), indents ( ), bacteria 
with altered morphology ( ), and deflated bags ( ). Representative images from two experiments 
performed in duplicate are shown. 
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3. Discussion 
The bacterial cytoplasmic membrane represents a valid drug target for the development of novel 
antimicrobial agents. The interactions of membrane-active AMPs with target membranes have been 
extensively studied in artificial systems, usually by using a relatively high peptide-to-lipid ratio. 
However, knowing the complexity of living microbial membranes, there is a need for a deeper 
characterization of AMP-induced effects on membranes of live bacteria. Therefore, in the present 
study, our goal was to set up a fluorescence assay for real-time monitoring of changes in membrane 
permeability induced by active peptide concentrations in whole bacteria. Specifically, we focused on 
Gram-positive microorganisms of medical relevance such as S. aureus and S. epidermidis. For the 
simultaneous monitoring of membrane depolarization and membrane permeabilization, we 
combined the membrane-impermeable nucleic acid stain PI with a potential-sensitive dye. We 
wanted to understand whether these two phenomena were clearly distinct or could be causally and 
temporally correlated, as suggested by other authors in the case of synthetic AMPs acting on 
Pseudomonas aeruginosa [62]. Therefore, the dye combination in our assay was conceptually different 
from the commercially available dual stain viability kit, based on two nucleic acid stains with 
different membrane permeability to discriminate between live and dead bacteria [63,64]. 
To investigate the complex phenomena occurring at the membrane level and related to 
membrane integrity, bacteria should be in an optimal growth phase with fully activated oxidative 
metabolism. Experiments were performed with S. aureus and S. epidermidis collected at their mid-log 
phase, washed and resuspended in physiological salt solution supplemented with 25 mM glucose as 
a carbon and energy source [47]. Given the short incubation time (30 min), this condition proved fully 
compatible with bacterial viability, as confirmed by fluorescence measurements and CFU counts. 
At difference with several published methods based on flow cytometry [65–67], our assay was 
set up in a 96-well microplate for fluorometric detection by using a microplate reader, equipped with 
temperature control. This allows for low assay volume, low reagent consumption, and simultaneous 
kinetic monitoring of multiple samples. Furthermore, by using a low-binding version of black 
microtiter plates (in our case OptiPlate, see Materials and Methods section) it was possible to 
overcome the problem of unspecific binding of hydrophobic compounds to microtiter plastic. This 
problem was addressed by other authors by using serum albumin in the assay mixture [34], but we 
preferred to avoid the use of this protein in our measurements due to possible unwanted 
sequestration of AMPs [68,69]. In our experience fluorescence detection with low-binding plates gave 
satisfactory results (see Supplementary Figure S2 for comparison between measurements of the 
carbocyanine diSC3(5) fluorescence in conventional and low-binding black microtiter plates). 
The initial combination of PI with the oxonol dye DiBAC4(3), at difference with the report of 
Clementi et al. [47], was not suitable for our assay due to strong interference between the two probes, 
probably due to an energy transfer phenomenon similar to Fluorescence Resonance Energy Transfer 
(FRET) from the oxonol to PI because of spectral overlap. We next replaced the oxonol with the 
carbocyanine dye diSC3(5), which has clearly distinct fluorescence parameters and did not show any 
interference with PI. By using the combination diSC3(5) + PI we were able to simultaneously monitor 
the kinetics of membrane depolarization and membrane permeabilization induced by well-
characterized membrane-targeting AMPs at bactericidal and sub-inhibitory concentrations. It is 
important to note, however, that PI fluorescence could only be detected with a sufficiently high 
bacterial density. In the case of the Gram-positive S. epidermidis and S. aureus, this corresponds to 108 
CFU/mL. We found that for the detection of both dyes together this suspension density was optimal, 
although a slightly lower density, i.e., 107 CFU/mL, would be sufficient for the detection of diSC3(5) 
only (see Supplementary Figure S3A,B). For PI detection in the case of Gram-negative 
microorganisms such as E. coli, a bacterial density of 107 CFU/mL would be sufficient thanks to their 
higher size and DNA content (see Supplementary Figure S3C,D). 
Concerning gramicidin D, our data are in line with those reported in the literature which reveals 
that gramicidin D causes a rapid and full dissipation of membrane potential by forming small cation 
specific channels [50,59,70]. In fact, many authors used this peptide as a positive control of membrane 
depolarization [34,71,72]. In those studies, however, gramicidin D was used at relatively high 
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concentrations to obtain complete depolarization, and it was often added at the end of the 
experiment. In our case, we focused on the suitability of our method for the detection of gramicidin-
induced effects and for this reason we explored a wide range of peptide concentrations. In all cases 
the increase of diSC3(5) fluorescence reached the same level, indicating complete membrane 
depolarization also at lower gramicidin concentrations. In this latter case, the delay could be due to 
an initial compensation by the microorganism that could not be pursued over a certain point resulting 
in a delayed, yet lethal effect. However, PI fluorescence did increase in any of the cases, even at the 
highest peptide concentrations. It is important to note in this regard that the diameter of gramicidin 
D-induced channels is estimated to measure about ≈4 Å, what is sufficient to accommodate the 
passage of monovalent cations [50], but not the uptake of larger molecules such as PI (MW = 668.4 
g/mol). As a consequence, the interaction of PI with nucleic acids is precluded despite bacteria dying. 
Our results (Figure 3) show that gramicidin D killed S. epidermidis and S. aureus by membrane 
depolarization without formation of larger pores that could enable PI uptake. As confirmed by CFU 
counts, the membrane depolarization induced by gramicidin D was the bactericidal event. Hence, 
any increase in PI fluorescence, recorded after several hours of incubation, as reported by some 
authors [73], should be rather regarded as a consequence of bacterial death. In fact, FE-SEM images 
showed a complex picture, including apparently intact bacteria, those with elongated shape showing 
some indents, others with surface blebs, and completely emptied bags. It is clear that all these 
modifications are representative of different dying steps that bacteria underwent upon gramicidin 
treatment. 
In the case of melittin (Figure 4), the increase of diSC3(5) fluorescence did not indicate a mode of 
action primarily based on membrane depolarization but was rather a consequence of irreversible 
membrane permeabilization, which appears as the key event. Curiously, by FE-SEM analysis we 
rarely noticed macroscopic membrane lesions. Instead, the appearance of the deflated or emptied bag 
would suggest that the emptying of cell content occurred due to osmotic imbalance or, alternatively, 
that membrane perturbation elicited an autolytic action. Melittin has long been considered as a 
paradigmatic pore-forming peptide [11,74–76]. Taking into consideration that melittin-induced 
pores, with a diameter of 25–30 Å [77], are large enough to accommodate the passage of large 
molecules such as PI, one can reasonably expect that inorganic ion leakage may also occur. So, in 
principle melittin would have the ability to alter membrane potential. It is interesting to note, 
however, that melittin at sub-optimal concentrations induced slower PI uptake, correlated with lower 
killing activity, but no increase of diSC3(5) fluorescence (Figure 4). In addition, at sub-inhibitory 
concentrations the increase of PI fluorescence never reached the high values observed at bactericidal 
concentrations (Figure 4). This observation would suggest a limited membrane damage, probably 
caused by the formation of transient pores, as reported in the literature [11,74], and that bacteria could 
recover by maintaining the proton motive force to some extent. 
The findings obtained thanks to the combination of both fluorescent dyes contribute to the 
advancement of our knowledge concerning the mode of action of gramicidin D and melittin. If for 
instance the assay would have been performed by using diSC3(5) only, we would conclude that both 
peptides, gramicidin D and melittin, act by causing membrane depolarization. On the contrary, if we 
had used only PI, we would speculate that gramicidin D, at the difference with melittin, did not cause 
membrane permeabilization and, perhaps killed bacteria by acting on some internal target(s). 
Conversely, by using the combination of diSC3(5) and PI, we measured the phenomena of 
membrane depolarization and permeabilization on the same bacteria population simultaneously. 
This assay thus enables us to distinguish between these two phenomena and contributes to shedding 
light on the mode of action of membrane-active agents such as the AMPs. This study confirmed that 
gramicidin D causes membrane depolarization and melittin induces membrane permeabilization. We 
also provide additional evidence that melittin at low concentrations probably creates transient pores 
causing membrane permeabilization which is reversible to some extent. 
We believe that this assay could be applied in investigations aimed at unraveling the mode of 
action of membrane-active AMPs, as well as for screening of novel compounds targeting the 
cytoplasmic membrane of S. aureus and S. epidermidis. 
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4. Materials and Methods 
4.1. Equipment 
Fluorometric measurements were performed with a Multimode Plate Reader (EnSpireTM 2300, 
PerkinElmer, Waltham, MA, USA) by using low-binding surface 96-black polystyrene microtiter 
plates (OptiPlate, PerkinElmer, Waltham, MA, USA ) to prevent unspecific binding of the molecules used 
in the study. 
4.2. Peptides and Other Reagents 
The selected membrane-active peptides gramicidin D (formyl-VGALAVVVWLWLWLWG-
NHCH2CH2OH), cecropin A (KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK-NH2), 
magainin 2 (GIGKFLHSAKKFGKAFVGEIMNS-OH), and melittin 
(GIGAVLKVLTTGLPALISWIKRKRQQ-NH2) were purchased from Sigma-Aldrich® (St. Louis, MO, 
USA). Cecropin A and gramicidin D were dissolved in DMSO and magainin 2 and melittin in 
pyrogenic water. The stock solutions were kept at −20 °C. The uncouplers carbonyl cyanide 3-
chlorophenylhydrazone (CCCP) and carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone 
(FCCP), the membrane potential-sensitive fluorescent distributional probes bis-(1,3-dibutylbarbituric 
acid)trimethine oxonol (DiBAC4(3)) and 3,3’-dipropylthiadicarbocyanine iodide (diSC3(5)), and the 
membrane-impermeable fluorescent dye propidium iodide (PI) were purchased from Sigma-Aldrich. 
Stock solutions were prepared as follows: 400 µM diSC3(5) in 100% DMSO, 50 µM DiBAC4(3) in 100% 
DMSO, and 1 mg/mL PI in ddH2O (PI would precipitate in a more concentrated solution). All stocks, 
were protected from light by aluminum foil and were stable at −20 °C for at least 6 months. 
4.3. Bacteria and Bacterial Cultures 
Two Gram-positive, Staphylococcus epidermidis ATCC 35984 and Staphylococcus aureus ATCC 
25923, and two Gram-negative, Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 
reference strains were obtained from American Type Culture Collection (ATCC; Manassas, VA, 
USA). Bacteria were maintained on Mueller–Hinton (MH, Difco laboratories, Detroit, MI, USA) agar 
plates. For antimicrobial assays, bacteria were cultured in liquid Brain Heart Infusion (BHI) 
overnight, 1:50-diluted in fresh medium and allowed to grow in an orbital shaker at 37 °C. Mid-log 
phase bacteria were harvested after 10 min centrifugation at 1000× g and resuspended in phosphate-
buffered solution (PBS) to optimal density assessed by turbidity at 600 nm, with reference to 
previously determined standards. For fluorescence kinetics, mid-log phase bacteria were collected by 
centrifugation at 1000× g, washed two times with PBS (pH 7.4), and finally resuspended in PBS 
supplemented with 25 mM glucose (PBS-glc) at the desired density. 
4.4. Determination of Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration 
(MBC) 
The minimum inhibitory concentration (MIC) of selected peptides was determined by a broth 
microdilution assay in 96-well microtiter plates, using MH broth with logarithmic-phase 
microorganisms at 5 × 105 CFU/mL, as previously reported [68], following CLSI guidelines. The 
minimum bactericidal concentration (MBC) was determined by seeding aliquots from wells showing 
no visible growth on solid medium to allow colony counts. 
4.5. Excitation and Emission Spectra 
To verify the correct excitation and emission wavelengths of each fluorescent dye, their 
excitation and emission spectra were measured in our assay conditions. DiBAC4(3) was studied at 
125, 250, and 500 nM (λex = 496 nm, λem = 516 nm) [53] plus PI at 10 µg/mL (λex = 490 nm, λem = 617 
nm) [52] in PBS supplemented with 25 mM glucose (PBS-glc). Furthermore, the excitation and 
emission spectra of 400 nM diSC3(5) alone (λex = 652 nm, λem = 672 nm) [53], and 400 nM diSC3(5) plus 
5, 10, and 20 µg/mL PI, were measured in PBS-glc. 
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4.6. Interference of Uncouplers and Peptides with the Fluorescent Dyes 
To verify whether uncouplers, peptides, and solvents have any interference with diSC3(5) or 
with PI, both fluorescent dyes (400 nM diSC3(5) and 5 µg/mL PI) combined together in the same wells 
of a black 96-well plate (Optiplate) were monitored kinetically for 30 minutes at 37 °C in PBS-glc in 
the presence of each selected molecule. 
4.7. Kinetic Fluorescence Measurements to Detect Membrane Depolarization and Permeabilization 
Mid-log phase S. epidermidis and S. aureus, resuspended at 1 × 108 CFU/mL in PBS-glc (prepared 
as described above) were incubated in the orbital shaker at 37 °C for 15 min. Thereafter, diSC3(5) and 
PI were added at final concentrations of 400 nM and 5 µg/mL, respectively. These concentrations 
were established in preliminary experiments and were optimal in our conditions (data not shown). 
The suspension was mixed by short vortexing and 200 µL was added to the wells of a black 96-well 
plate (Optiplate). Samples were preincubated at 37 °C with fluorescence measurements every minute 
for 5 min, or until readings were stabilized. After this time, the plate was ejected. Depolarizing agents 
were added in duplicate wells at the desired final concentrations. The plate was rapidly placed back 
into the reader to continue monitoring diSC3(5) and PI (diSC3(5); λex = 652, λem = 672 nm and PI; λex = 
535, λem = 617 nm) [54], every 0.5 min for 10–20 min. At the end of incubation (around 30 min), aliquots 
were withdrawn from each well, serially diluted and plated on MH agar to allow CFU determination. 
The killing percentage was calculated with reference to untreated samples. 
4.8. Field Emission Scanning Electron Microscopy (FE-SEM) of S. epidermidis 
The morphology of S. epidermidis, deposited on polycarbonate filters, were studied by Field 
Emission Scanning Electron Microscopy (FE-SEM) (JEOL model JSM-7610FPlus). Briefly, upon 30 
min incubation, as described above, all samples were collected by centrifugation at 1000× g for 10 min 
and fixed with 2.5% (v/v) glutaraldehyde in PBS for 1 h at 4 °C. Fixed bacteria were extensively rinsed 
with filtered sterile PBS and dehydrated in graded series of ethanol solutions (20 min each) by 
centrifuging at each step. Finally, samples were deposited on 0.2 µm Isopore polycarbonate 
membrane filters (MerckMillipore, Burlington, MA, USA) and sputter-coated with a thin gold layer 
prior to FE-SEM analysis. The images were collected in the secondary electron detection mode. The 
working distance was set to 8 mm, the acceleration voltage to 5 keV, and the probe current to 11 to 
decrease the interaction depth and obtain more detailed information on the surface. FE-SEM was 
performed in duplicate for each sample. 
Supplementary Materials: The following are available online at www.mdpi.com/xxx/s1, Figure S1: Separate 
fluorescence Excitation (A,C) and Emission (B,D) spectra of bis-(1,3-dibutylbarbituric acid)trimethine oxonol 
(DiBAC4(3)) (A–B) and propidium iodide (PI) (C–D) in phosphate-buffered saline supplemented with 25 mM 
glucose (PBS-glc). (A,C) Excitation spectra of 500 nM DiBAC4(3) with 516 nm (A) and 20 µg/mL PI with 617 nm 
(C) detection wavelengths. (B,D) Emission spectra of 500 nM DiBAC4(3) with 496 nm (B) and 20 µg/mL PI with 
490 nm (D) excitation wavelengths. For technical reasons due to instrument settings, spectra could not be 
measured at wavelengths >496 nm (A) and <510 nm (B), Figure S2: Fluorescence Excitation and Emission spectra 
of 400 nM nM 3,3'-dipropylthiadicarbocyanine Iodide (diSC3(5)) in black wellplates (A,B) and low-binding 
OptiPlate (C,D). (A,C) Excitation spectra with 672 nm detection wavelength, and (B,D) emission spectra with 
652 nm excitation wavelength (error bars were omitted for clarity). For technical reasons due to instrument 
settings, spectra could not be measured at wavelengths >650 nm (A,C) and <670 nm (B,D), Figure S3: Membrane 
depolarization (diSC3(5)) (A) and Killing (B) of S. epidermidis ATCC 35984 caused by gramicidin D and membrane 
permeabilization (PI) (C) and Killing (D) of E.coli ATCC 25,922 caused by melittin. Experiments were performed 
with 107 CFU/mL of the indicated strains in PBS-glc with 400 nM diSC3(5) (λex = 652 nm, λem = 672 nm) and 5 
µg/mL PI (λex = 535 nm, λem = 617 nm) at 37 °C. CFU counts were determined at 30 min incubation. (*) peptide 
addition. 
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